Transposon-preview

Transposon

Private

San Diego, CaliforniaHealthcare & Life Scienceswww.transposonrx.com

Last Round

Grant

Mar 4, 2026

Total Funding Raised

$59.11M

Company Overview

Transposon is a biotechnology company focused on developing innovative drugs for neurodegenerative diseases and age-related conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

TPN-101LINE-1 reverse transcriptase inhibitorneurodegenerative disease therapyfirst-in-class therapyLINE-1 inhibitorCensavudineneuroinflammation treatmentsmall molecule drugAlzheimer's disease treatmentProgressive Supranuclear PalsyPSPAmyotrophic Lateral SclerosisALSLINE-1 retrotransposonsorally administered therapydrug discovery platformnucleoside analogs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Transposon Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Transposon Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Mar 4, 2026
Grant	Jul 9, 2025
Debt	Jul 15, 2024
VC Round	Jan 12, 2023
Series A	Dec 9, 2020
Seed	May 6, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Eckard Weber

Founder And Chief Innovation Officer

Founding Team

Lynne Rollins

CFO

Executive Team

Transposon Investors

Notable investors and investment history

Investor	Rounds
Domain Associates	Seed, Series A, VC Round
Canaan Partners	Seed, Series A, VC Round
Catalys Pacific	Series A
ARPA-H	Grant
Lumira Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 4, 2026
$22M grant round closed.

View all signals

Transposon Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Transposon Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Transposon's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California

Employee Range12

Year Founded2019

Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.